|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.5 GBX | -1.21% |
|
-7.20% | -2.78% |
| Feb. 29 | Oncimmune Holdings plc Provides Earnings Guidance for the Year 2024 | CI |
| Feb. 29 | Oncimmune Holdings plc Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
Oncimmune Holdings plc reported earnings results for the full year ended May 31, 2022. For the full year, the company reported sales was GBP 3.86 million compared to GBP 3.72 million a year ago. Net loss was GBP 9.51 million compared to GBP 4.63 million a year ago.
Basic loss per share from continuing operations was GBP 0.137 compared to GBP 0.0717 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.78% | 22.57M | |
| +5.73% | 70.78B | |
| +11.79% | 9.15B | |
| -15.34% | 4.84B | |
| +34.54% | 4.22B | |
| +5.09% | 3.92B | |
| +27.76% | 2.55B | |
| -28.33% | 2.24B | |
| -24.15% | 2.26B | |
| +6.23% | 1.92B |
ONCIMMUNE HOLDINGS PLC 
